Michael Gregory

Michael Gregory is a prominent figure in the biotechnology and healthcare investment sector. Here are the key details about him:

Professional Background

Michael Gregory is the Co-Managing Partner and Co-Founder of Avidity Partners, a biotechnology/healthcare-focused investment management firm.1 He serves as Director of Research and President at the company.3

Career History

• Prior to co-founding Avidity Partners in 2019, Gregory held several notable positions:
  • Head of Healthcare and CIO of Highland Alternative Investors at Highland Capital Management from 2010 to 20182
  • Founder and Portfolio Manager of Cummings Bay Capital Management from 2006 to 20102

Education

• MBA from Yale University, completing a specialized joint program in healthcare within the Yale Schools of Medicine, Management and Public Policy1
• BS in Economics from the University of Pennsylvania's Wharton School of Business1

Board Memberships and Affiliations

Gregory is actively involved in various academic and scientific boards, including:

• University of Texas Southwestern Medical Center
• The University of Texas Center for Brain Health
• Alliance for Cancer Gene Therapy
• Fellow of the Royal Society of Medicine1

Investment Expertise

With over a decade of experience as a healthcare investor, Gregory has established himself as a respected figure in the field.3 At Avidity Partners, he leads a seasoned research team focusing on investments in public and private biotechnology and healthcare companies.1

Michael Gregory's LinkedIn profile can be found under the username michael-gregory-3895632b.2